Option Care Health (OPCH) to Release Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, April 23rd. Analysts expect the company to announce earnings of $0.23 per share for the quarter. Option Care Health has set its FY 2024 guidance at EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, February 22nd. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The business had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the previous year, the company posted $0.26 earnings per share. Option Care Health’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, analysts expect Option Care Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Option Care Health Stock Performance

Shares of OPCH stock opened at $30.91 on Tuesday. The stock’s fifty day simple moving average is $32.37 and its 200-day simple moving average is $31.61. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. Option Care Health has a 1-year low of $24.23 and a 1-year high of $35.74. The company has a market capitalization of $5.37 billion, a price-to-earnings ratio of 21.03, a P/E/G ratio of 1.73 and a beta of 1.22.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the firm’s stock in a transaction dated Monday, February 26th. The stock was bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the purchase, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

Large investors have recently made changes to their positions in the stock. Advisors Asset Management Inc. lifted its position in shares of Option Care Health by 121.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company’s stock worth $42,000 after purchasing an additional 733 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Option Care Health by 1,031.9% during the 1st quarter. NewEdge Advisors LLC now owns 1,562 shares of the company’s stock worth $50,000 after purchasing an additional 1,424 shares during the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Option Care Health by 39.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,236 shares of the company’s stock worth $70,000 after purchasing an additional 629 shares during the last quarter. Covestor Ltd lifted its position in shares of Option Care Health by 122.8% during the 1st quarter. Covestor Ltd now owns 3,610 shares of the company’s stock worth $103,000 after purchasing an additional 1,990 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its position in shares of Option Care Health by 1,513.7% during the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock worth $103,000 after purchasing an additional 2,876 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on OPCH. Jefferies Financial Group boosted their target price on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research boosted their target price on Option Care Health from $35.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday, February 23rd.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.